Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Drawback: Methylcellulose provides no prebiotic benefit
At day 168, mean relative VASI improvement was 48.64% (95% CI 39.4957.80) with combination therapy versus 33.26% (24.1842.33) with NBUVB alone
Contact your healthcare provider promptly if you experience: Severe or worsening injection site reactions including extensive redness, swelling, warmth, or pain that spreads beyond the immediate injection area, or reactions that persist for more than a few days Signs of possible allergic reaction such as widespread rash, hives, itching, facial swelling, difficulty breathing, rapid heartbeat, or dizziness Unexplained changes in blood glucose control if you have diabetes, particularly if home glucose monitoring shows consistently elevated readings despite medication adherence Sudden loss of appetite suppression or return of intense hunger after previously experiencing good control Unexpected weight regain without changes in diet or physical activity New or unusual symptoms that concern you or differ from your previous experience with the medication Seek emergency medical attention immediately (call 911) for: Difficulty breathing or swallowing Severe swelling of the face, lips, tongue, or throat Rapid heartbeat with chest tightness Severe dizziness or fainting Widespread hives or rash developing rapidly after injection These symptoms may indicate anaphylaxis or serious hypersensitivity, which require urgent evaluation and treatment regardless of antibody status
Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes
In one pooled analysis, the risk of kidney failure dropped by 22%, offering a protective benefit beyond blood sugar control
